Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krishnan Ramanathan

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
The American Journal of Cardiology|November 6, 2012
Treatment and outcomes of patients with suspected acute coronary syndromes in relation to initial diagnostic impressions (insights from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE])Ravi R Bajaj, Shaun G Goodman, Raymond T Yan, et al.
Journal of the American College of Cardiology|December 16, 2017
Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary SyndromesKrishnan Ramanathan, James G Abel, Julie E Park, et al.
Neurology and Therapy|December 19, 2022
Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS TrialAmit Bar-Or, Xavier Montalban, Xixi Hu, et al.
Heart Rhythm|January 7, 2018
Clinical effectiveness of a systematic "pill-in-the-pocket" approach for the management of paroxysmal atrial fibrillationJason G Andrade, Jenny MacGillivray, Laurent Macle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 17, 2021
Effect of ofatumumab versus placebo in relapsing multiple sclerosis patients from Japan and Russia: Phase 2 APOLITOS studyJun-Ichi Kira, Jin Nakahara, Denis V Sazonov, et al.
CNS Drugs|March 2, 2022
Population Pharmacokinetic-B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple SclerosisHuixin Yu, Gordon Graham, Olivier J David, et al.
American Heart Journal|August 13, 2011
Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromesBasem Elbarouni, Nabeel Ismaeil, Raymond T Yan, et al.
Journal of the American College of Cardiology|April 30, 2016
Long-Term Post-Discharge Risks in Older Survivors of Myocardial Infarction With and Without Out-of-Hospital Cardiac ArrestChristopher B Fordyce, Tracy Y Wang, Anita Y Chen, et al.
Frontiers in Immunology|April 18, 2022
Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II TrialsTjalf Ziemssen, Douglas L Arnold, Enrique Alvarez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2022
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and IIJutta Gärtner, Stephen L Hauser, Amit Bar-Or, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
The American Journal of Cardiology|November 6, 2012
Treatment and outcomes of patients with suspected acute coronary syndromes in relation to initial diagnostic impressions (insights from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE])Ravi R Bajaj, Shaun G Goodman, Raymond T Yan, et al.
Journal of the American College of Cardiology|December 16, 2017
Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary SyndromesKrishnan Ramanathan, James G Abel, Julie E Park, et al.
Neurology and Therapy|December 19, 2022
Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS TrialAmit Bar-Or, Xavier Montalban, Xixi Hu, et al.
Heart Rhythm|January 7, 2018
Clinical effectiveness of a systematic "pill-in-the-pocket" approach for the management of paroxysmal atrial fibrillationJason G Andrade, Jenny MacGillivray, Laurent Macle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 17, 2021
Effect of ofatumumab versus placebo in relapsing multiple sclerosis patients from Japan and Russia: Phase 2 APOLITOS studyJun-Ichi Kira, Jin Nakahara, Denis V Sazonov, et al.
CNS Drugs|March 2, 2022
Population Pharmacokinetic-B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple SclerosisHuixin Yu, Gordon Graham, Olivier J David, et al.
American Heart Journal|August 13, 2011
Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromesBasem Elbarouni, Nabeel Ismaeil, Raymond T Yan, et al.
Journal of the American College of Cardiology|April 30, 2016
Long-Term Post-Discharge Risks in Older Survivors of Myocardial Infarction With and Without Out-of-Hospital Cardiac ArrestChristopher B Fordyce, Tracy Y Wang, Anita Y Chen, et al.
Frontiers in Immunology|April 18, 2022
Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II TrialsTjalf Ziemssen, Douglas L Arnold, Enrique Alvarez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2022
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and IIJutta Gärtner, Stephen L Hauser, Amit Bar-Or, et al.
Pageof 7